وزارة الصحة ووقاية المجتمع ترخيص رقم: DLV3GF2R-130922
English
توصيل مجاني على جميع الطلبات!
Aerinaze is a medicine containing the active substances desloratadine (2.5 mg) and pseudoephedrine (120 mg). It is available as blue and white modified-release tablets. ‘Modified-release’ means that the tablets have been made to allow one of the active substances to be released immediately and the other one released over a few hours.
Aerinaze is used to treat the symptoms of seasonal allergic rhinitis (hay fever, inflammation of the nasal passages caused by an allergy to pollen) in patients who have nasal congestion (a blocked nose). The medicine can only be obtained with a prescription.